References
- Schmidli J, Widmer MK, Basile C, et al. Editor’s Choice - Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:757–818.
- Arbanasi EM, Russu E, Muresan AV, Arbanasi EM, Kaller R. Ulnar-basilic arteriovenous fistula with multilocular gigantic aneurysmal dilatation: a case report. Acta Marisiensis - Seria Medica. 2021;67:244–246.
- Kaller R, Mureșan AV, Arbănași EM, et al. Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure. Life. 2022;12:529.
- Russu E, Muresan AV, Arbanasi EM, et al. Polytetrafluorethylene Prosthesis Interposition in Vascular Access. Materiale Plastice. 2022;59:1–8.
- Duque JC, Tabbara M, Martinez L, Cardona J, Vazquez-Padron RI, Salman LH. Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure. Am J Kidney Dis. 2017;69:147–151.
- Martinez L, Duque JC, Tabbara M, et al. Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas. J Am Soc Nephrol. 2018;29:1030–1040.
- Mureșan AV, Russu E, Arbănași EM, et al. The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines. 2022;10:1272.
- Matsubara Y, Kiwan G, Fereydooni A, Langford J, Dardik A. Distinct subsets of T cells and macrophages impact venous remodeling during arteriovenous fistula maturation. JVS Vasc Sci. 2020;1:207–218.
- Campos B, Lee T, Roy-Chaudhury P. Arteriovenous fistula failure: is there a role for epigenetic regulation? Semin Nephrol. 2013;33:400–406.
- Gameiro J, Ibeas J. Factors affecting arteriovenous fistula dysfunction: A narrative review. J Vasc Access. 2020;21:134–147.
- Morton SK, Rodríguez AJ, Morris DR, Bhandari AP, Moxon JV, Golledge J. A Systematic Review and Meta-Analysis of Circulating Biomarkers Associated with Failure of Arteriovenous Fistulae for Haemodialysis. PLoS ONE. 2016;11:e0159963.
- Kaygin MA, Halici U, Aydin A, et al. The relationship between arteriovenous fistula success and inflammation. Renal Failure. 2013;35:1085–1088.
- Yilmaz H, Bozkurt A, Cakmak M, et al. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil-lymphocyte ratio (NLR) in chronic hemodialysis patients. Renal Failure. 2014;36:1390–1394.
- Usman R, Jamil M, Naveed M. High Preoperative Neutrophil-Lymphocyte Ratio (NLR) and Red Blood Cell Distribution Width (RDW) as Independent Predictors of Native Arteriovenous Fistula Failure. Ann Vasc Dis. 2017;10:205–210.
- Stirbu O, Gadalean F, Pitea IV, et al. C-reactive protein as a prognostic risk factor for loss of arteriovenous fistula patency in hemodialyzed patients. J Vasc Surg. 2019;70:208–215.
- Kordzadeh A, Tokidis E, Askari A, Hoff M, Panayiotopoulos Y. The independent association of preoperative serum albumin on the functional maturation of radiocephalic arteriovenous fistulae. J Vasc Access. 2017;18:148–152.
- Wongmahisorn Y. Role of neutrophil-to-lymphocyte ratio as a prognostic indicator for hemodialysis arteriovenous fistula failure. J Vasc Access. 2019;20:608–614.
- Martinez-Mier G, Camargo-Diaz C, Urbina-Velazquez MA, Avila-Pardo SF. Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico. Ann Vasc Surg. 2020;62:304–309.
- Lano G, Sallée M, Pelletier M, et al. Mean Platelet Volume Predicts Vascular Access Events in Hemodialysis Patients. J Clin Med. 2019;8:608.
- Sarioglu O, Capar AE, Belet U. Relationship of arteriovenous fistula stenosis and thrombosis with the platelet–lymphocyte ratio in hemodialysis patients. J Vasc Access. 2020;21:630–635.
- Bilican G, Oguz EG, Yayar O, et al. Usefulness of mean platelet volume as a biomarker for diagnosing arterivenosus fistulas thrombosis in routine hemodialysis patients. Ann Med Res. 2020;27:0895–0902.
- Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels’ Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12:1447.
- Pasqui E, de Donato G, Lazzeri E, et al. High Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Are Associated with a Higher Risk of Hemodialysis Vascular Access Failure. Biomedicines. 2022;10:2218.
- Baek J, Lee H, Yang T, et al. Plasma Interleukin-6 Level Predicts the Risk of Arteriovenous Fistula Dysfunction in Patients Undergoing Maintenance Hemodialysis. J Pers Med. 2023;13:151.
- Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. Journal of Clinical Medicine. 2023;12:4419.
- de Vries MR, Simons KH, Jukema JW, Braun J, Quax PHA. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol. 2016;13:451–470.
- Sadaghianloo N, Contenti J, Dardik A, Mazure NM. Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas. Int J Mol Sci. 2019;20:5387.
- Brownson KE, Khosravi R, Lee SR, et al. Venous Mechanical Properties After Arteriovenous Fistulae in Mice. J Surg Res. 2020;248:129–136.
- Yang Q, Lei D, Huang S, et al. Effects of the different-sized external stents on vein graft intimal hyperplasia and inflammation. Ann Transl Med. 2020;8:102.